ClinicalTrials.gg
CompletedNCT01592851Updated Jun 3, 2014Results posted

Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity

A Phase 3 interventional study of Stannous Fluoride and Sodium Monofluorophosphate in Dentine Hypersensitivity, sponsored by GlaxoSmithKline. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-06-03.

Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
113
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 28 studies in Dentin Sensitivity by GlaxoSmithKline — none open to participants now, none under way, none of them phase 3. Dentin Sensitivity · GlaxoSmithKline.

Enrollment
23rd of 28
113 · median 164
Started
2012
with 3 others
Phase 3
5 of 28
none open now
Registered
3rd of 28
by date

Among the 28 studies in Dentin Sensitivity by GlaxoSmithKline, this one is the 23rd largest by enrollment, is one of 4 that started in 2012, is one of 5 in phase 3, and was the 3rd registered.

Dentin Sensitivity

290 studies on the registry are indexed under Dentin Sensitivity; 48 are open to participants now.

Browse Dentin Sensitivity studies →

Open to participants now

None of the 28 studies in Dentin Sensitivity by GlaxoSmithKline is open now. The open studies under Dentin Sensitivity, anywhere →

Who these studies take

Of the 19 Dentin Sensitivity studies recruiting now, 6 (32%) set no upper age limit and 12 (63%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 28 studies in Dentin Sensitivity by GlaxoSmithKline as a file.
02

Study summary

A study to compare the efficacy of a test dentifrice against a control dentifrice in reducing dentinal hypersensitivity over a two week treatment period.

03

Conditions studied

  • Dentine Hypersensitivity

Browse trials for

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

- Subjects who suffer from tooth sensitivity.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
113 participants (actual)

Study arms

  • Experimental
    Arm 1

    Dentifrice containing stannous fluoride

    Drug: Stannous Fluoride

  • Active comparator
    Arm 2

    Marketed dentifrice containing Sodium Monofluorophosphate

    Drug: Sodium Monofluorophosphate

Interventions

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 14

    Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus. Those teeth that met the tactile threshold inclusion criterion (tactile threshold ≤ 20g) were assessed at baseline and Day 14. The Investigator directed a second application of air from a standard dental syringe to the facial surface of the two sensitive teeth selected at baseline. The Schiff Sensitivity Score was calculated as the subject level mean change (on two teeth) from baseline.

    Time frame: Baseline to Day 14

Secondary outcomes

  1. Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale Immediately Post-treatment

    Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus. Those teeth that met the tactile threshold inclusion criterion (tactile threshold ≤ 20g) were assessed at baseline and immediately after treatment. The Investigator directed a second application of air from a standard dental syringe to the facial surface of the two sensitive teeth selected at baseline. The Schiff Sensitivity Score was calculated as the subject level mean change (on two teeth) from baseline.

    Time frame: Baseline to immediately post treatment administration

  2. Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 3

    Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus. Those teeth that met the tactile threshold inclusion criterion (tactile threshold ≤ 20g) were assessed at baseline and Day 3. The Investigator directed a second application of air from a standard dental syringe to the facial surface of the two sensitive teeth selected at baseline. The Schiff Sensitivity Score was calculated as the subject level mean change (on two teeth) from baseline.

    Time frame: Baseline to Day 3

  3. Change From Baseline in Tactile Pain Threshold Score at Day 14

    The Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale (10g to 80g). According to this tactile sensitivity assessment, an increasing force is applied to hypersensitive tooth until a yes response to pain is recorded or the maximum force has been reached. Tactile testing begins with a force of 10g and it is increased by 10g, with each successive challenge, until either a "yes" response is recorded or the maximum force (80g) is reached. An increase in tactile score from baseline represents an improvement in sensitivity

    Time frame: Baseline to Day 14

  4. Change From Baseline in Tactile Pain Threshold Score at Day 3

    The Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale (10g to 80g). According to this tactile sensitivity assessment, an increasing force is applied to hypersensitive tooth until a yes response to pain is recorded or the maximum force has been reached. Tactile testing begins with a force of 10g and it is increased by 10g, with each successive challenge, until either a "yes" response is recorded or the maximum force (80g) is reached. An increase in tactile score from baseline represents an improvement in sensitivity.

    Time frame: Baseline to Day 3

  5. Change From Baseline in Tactile Pain Threshold Score Immediately Post-treatment

    The Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale (10g to 80g). According to this tactile sensitivity assessment, an increasing force is applied to hypersensitive tooth until a yes response to pain is recorded or the maximum force has been reached. Tactile testing begins with a force of 10g and it is increased by 10g, with each successive challenge, until either a "yes" response is recorded or the maximum force (80g) is reached. An increase in tactile score from baseline represents an improvement in sensitivity.

    Time frame: Baseline to immediately post treatment administration

07

Results

Posted Jun 3, 2014

Participant flow

Participants were recruited at the clinical site.

Participant flow — Overall Study
MilestoneStannous Fluoride (SnF) DentifriceSodium Monofluorophosphate (NaMFP) Dentifrice
Started5657
Completed5657
Not completed00

Outcome measures

PrimaryChange From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 14

Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus. Those teeth that met the tactile threshold inclusion criterion (tactile threshold ≤ 20g) were assessed at baseline and Day 14. The Investigator directed a second application of air from a standard dental syringe to the facial surface of the two sensitive teeth selected at baseline. The Schiff Sensitivity Score was calculated as the subject level mean change (on two teeth) from baseline.

Time frame:
Baseline to Day 14
Reported as:
Mean · Score on a scale
Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 14
Score on a scaleSnF DentifriceNaMFP Dentifrice
Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 14-1.20 ± 0.70-0.37 ± 0.43
Statistical analysis
  • SnF Dentifrice vs NaMFP Dentifrice · ANCOVA · p = <0.0001 (No adjustment made for multiple comparisons, as primary comparison was pre-specified.) · Adjusted mean difference: -0.83 · 95% CI -1.03 to -0.63Difference is 0.454% SnF minus 0.76% NaMFP such that a negative difference favours first named treatment.
SecondaryChange From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale Immediately Post-treatment

Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus. Those teeth that met the tactile threshold inclusion criterion (tactile threshold ≤ 20g) were assessed at baseline and immediately after treatment. The Investigator directed a second application of air from a standard dental syringe to the facial surface of the two sensitive teeth selected at baseline. The Schiff Sensitivity Score was calculated as the subject level mean change (on two teeth) from baseline.

Time frame:
Baseline to immediately post treatment administration
Reported as:
Mean · Score on a scale
Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale Immediately Post-treatment
Score on a scaleSnF DentifriceNaMFP Dentifrice
Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale Immediately Post-treatment-0.40 ± 0.46-0.14 ± 0.35
Statistical analysis
  • SnF Dentifrice vs NaMFP Dentifrice · ANCOVA · p = 0.0006 (No adjustment made for multiple comparisons, as primary comparison was pre-specified.) · Adjusted mean difference: -0.26 · 95% CI -0.41 to -0.12Difference is 0.454% SnF minus 0.76% NaMFP such that a negative difference favours first named treatment.
SecondaryChange From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 3

Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus. Those teeth that met the tactile threshold inclusion criterion (tactile threshold ≤ 20g) were assessed at baseline and Day 3. The Investigator directed a second application of air from a standard dental syringe to the facial surface of the two sensitive teeth selected at baseline. The Schiff Sensitivity Score was calculated as the subject level mean change (on two teeth) from baseline.

Time frame:
Baseline to Day 3
Reported as:
Mean · Score on a scale
Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 3
Score on a scaleSnF DentifriceNaMFP Dentifrice
Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 3-0.70 ± 0.60-0.25 ± 0.39
Statistical analysis
  • SnF Dentifrice vs NaMFP Dentifrice · ANCOVA · p = <0.0001 (No adjustment made for multiple comparisons, as primary comparison was pre-specified.) · Adjusted mean difference: -0.45 · 95% CI -0.63 to -0.28Difference is 0.454% SnF minus 0.76% NaMFP such that a negative difference favours first named treatment.
SecondaryChange From Baseline in Tactile Pain Threshold Score at Day 14

The Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale (10g to 80g). According to this tactile sensitivity assessment, an increasing force is applied to hypersensitive tooth until a yes response to pain is recorded or the maximum force has been reached. Tactile testing begins with a force of 10g and it is increased by 10g, with each successive challenge, until either a "yes" response is recorded or the maximum force (80g) is reached. An increase in tactile score from baseline represents an improvement in sensitivity

Time frame:
Baseline to Day 14
Reported as:
Mean · Force (grams)
Change From Baseline in Tactile Pain Threshold Score at Day 14
Force (grams)SnF DentifriceNaMFP Dentifrice
Change From Baseline in Tactile Pain Threshold Score at Day 1422.9 ± 21.143.5 ± 5.67
Statistical analysis
  • SnF Dentifrice vs NaMFP Dentifrice · ANCOVA · p = <0.0001 (No adjustment made for multiple comparisons, as primary comparison was pre-specified.) · Adjusted mean difference: 19.42 · 95% CI 13.70 to 25.15Difference is 0.454% SnF minus 0.76% NaMFP such that a positive difference favours first named treatment.
SecondaryChange From Baseline in Tactile Pain Threshold Score at Day 3

The Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale (10g to 80g). According to this tactile sensitivity assessment, an increasing force is applied to hypersensitive tooth until a yes response to pain is recorded or the maximum force has been reached. Tactile testing begins with a force of 10g and it is increased by 10g, with each successive challenge, until either a "yes" response is recorded or the maximum force (80g) is reached. An increase in tactile score from baseline represents an improvement in sensitivity.

Time frame:
Baseline to Day 3
Reported as:
Mean · Force (grams)
Change From Baseline in Tactile Pain Threshold Score at Day 3
Force (grams)SnF DentifriceNaMFP Dentifrice
Change From Baseline in Tactile Pain Threshold Score at Day 39.8 ± 15.523.0 ± 4.90
Statistical analysis
  • SnF Dentifrice vs NaMFP Dentifrice · ANCOVA · p = 0.0021 (No adjustment made for multiple comparisons, as primary comparison was pre-specified.) · Adjusted mean difference: 6.84 · 95% CI 2.54 to 11.13Difference is 0.454% SnF minus 0.76% NaMFP such that a positive difference favours first named treatment.
SecondaryChange From Baseline in Tactile Pain Threshold Score Immediately Post-treatment

The Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale (10g to 80g). According to this tactile sensitivity assessment, an increasing force is applied to hypersensitive tooth until a yes response to pain is recorded or the maximum force has been reached. Tactile testing begins with a force of 10g and it is increased by 10g, with each successive challenge, until either a "yes" response is recorded or the maximum force (80g) is reached. An increase in tactile score from baseline represents an improvement in sensitivity.

Time frame:
Baseline to immediately post treatment administration
Reported as:
Mean · Force (grams)
Change From Baseline in Tactile Pain Threshold Score Immediately Post-treatment
Force (grams)SnF DentifriceNaMFP Dentifrice
Change From Baseline in Tactile Pain Threshold Score Immediately Post-treatment5.8 ± 10.171.9 ± 3.24
Statistical analysis
  • SnF Dentifrice vs NaMFP Dentifrice · ANCOVA · p = 0.0070 (No adjustment made for multiple comparisons, as primary comparison was pre-specified.) · Adjusted mean difference: 3.87 · 95% CI 1.08 to 6.65Difference is 0.454% SnF minus 0.76% NaMFP such that a positive difference favours first named treatment.

Adverse events

Collected over All adverse events encountered or spontaneously reported following administration of any investigational product, or for up to 5 days after the last administration of investigational product were recorded.. Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
SnF Dentifrice—0/56 (0%)0/56 (0%)
NaMFP Dentifrice—0/57 (0%)0/57 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)SnF DentifriceNaMFP DentifriceTotal
Mean38.1 ± 10.7034.8 ± 9.8636.5 ± 10.37
Sex: Female, Male
Sex: Female, Male(Participants)SnF DentifriceNaMFP DentifriceTotal
Female374279
Male191534
08

Study locations

1 site
  • BioSci Research America, Inc.
    Las Vegas, Nevada 89121, United States
09

References and documents

Publications

  • Parkinson CR, Hughes N, Hall C, Whelton H, Gallob J, Mason S. Three randomized clinical trials to assess the short-term efficacy of anhydrous 0.454% w/w stannous fluoride dentifrices for the relief of dentin hypersensitivity. Am J Dent. 2016 Feb;29(1):25-32. PubMed 27093773 ↗
10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2012, a primary completion of May 2012 and a completion of May 2012. It does not say whether these dates are actual or estimated.

Results were first posted in Jun 2014, 2 years 1 month after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
May 3, 2012
First posted
May 7, 2012
Start
Apr 2012
Primary completionActual
May 2012
CompletionActual
May 2012
Results first posted
Jun 3, 2014
Last update
Jun 3, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01592851
Lead sponsor
GlaxoSmithKline
Responsible party
Sponsor
First posted
May 7, 2012
Start date
Apr 2012
Primary completion
May 2012
Completion
May 2012
Results posted
Jun 3, 2014
Last update
Jun 3, 2014

Study contacts

GSK Clinical Trials
study director · GlaxoSmithKline

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tin Fluorides

Start the discussion